Skip to main content
SpringerLink
Log in

Immunological Treatments for Autism

  • Published:
Journal of Autism and Developmental Disorders Aims and scope Submit manuscript

Abstract

Several investigators, including ourselves, have reported significant changes in various immune responses in children with autism. These changes demonstrate dysregulation of the immune system (deficiency in some components of the immune system and excesses in others). In addition, certain genes in the major histocompatibility complex (that regulates immune responses) appear to be involved in autism. Based upon immunological abnormalities, various treatment modalities have been applied to children with autism. In this brief review, these immunological changes and various biological therapies are analyzed and summarized.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  • Cardinali, D. P. (1977). Effect of pentoxifylline and theophylline on neurotransmitter uptake and release by synaptosome-rich homogenates of the rat hypothalamus. Neuropharmacology, 16, 785–790.

    PubMed  Google Scholar 

  • Fiers, W., & Buurman, W. A. (Eds). (1993). Tumor necrosis factor: Molecular and Cellular Biology and Clinical Relevance. Basel, Switzerland: Karger.

    Google Scholar 

  • Fudenberg, H. H. (1996). Dialyzable lymphocyte extract (DlyE) in infantile onset autism: A pilot study. Biotherapy, 9, 143–147.

    PubMed  Google Scholar 

  • Gupta, S. (1998). Intravenous immunoglobulin therapy in neurological disorders. Western Journal of Medicine, 167, 349–350.

    Google Scholar 

  • Gupta, S. (1999). Treatment of children with autism with intravenous immunoglobulin. Journal of Child Neurology, 14, 203.

    PubMed  Google Scholar 

  • Gupta, S., Aggarwal S., & Heads, C. (1996). Dysregulated immune system in children with autism: Beneficial effects of intravenous immune globulin on autistic characteristics. Journal of Autism and Developmental Disorders, 26, 439–452.

    PubMed  Google Scholar 

  • Gupta, S., Lee, T., & Aggarwal, S. (1998). Alterations in Th1 and Th2 subsets of CD4??and CD8??T cells in autism. Journal of Neuroimmunology, 14, 499–504.

    Google Scholar 

  • Gupta, S., Rimland, B., & Shilling, P. D. (1996) Pentoxyfylline: A brief review and rationale for its possible use in the treatment of autism. Journal of Child Neurology, 11, 501–504.

    PubMed  Google Scholar 

  • Hawkins, E. S., & Ribeiro, H. A. (1987). Pentoxifylline review. Journal of American Podiatric Medical Association, 77, 645–647.

    Google Scholar 

  • Kitatani, T., Watanabe, T., & Shibuya, T. (1993). Different effects of methyxanthines on central serotonergic postsynaptic neurons in a mouse behavioral model. Pharmacology Biochemical Behavior, 44, 457–461.

    Google Scholar 

  • Menage, P., Thibault, G., Barthelemy, C., Lelford, G., & Bardos, P. (1992). CD4??CD45RA??T lymphocyte deficiency in autistic children: Effect of a pyridoxin-magnesium treatment. Brain Dysfunction, 5, 326–333.

    Google Scholar 

  • Mintz, M., Rapaport, R., Oleske, J. M., Connor, E. A., Koenigsberger, M. R., & Denny, T. (1989). Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. American Journal of Diseases of Children, 143, 771–774.

    PubMed  Google Scholar 

  • Mountz, J. M., Tolbert, L. C., Lill, D. W., Katholic, C. R., & Liu, H. G. (1995). Functional deficits in autistic disorder: Characterization by technetium-99m-HMPAO and SPECT. Journal of Nuclear Medicine, 38, 1156–1162.

    Google Scholar 

  • Plioplys, A. V. (1998). Intravenous immunoglobulin treatment of children with autism. Journal of Child Neurology, 13, 79–82.

    PubMed  Google Scholar 

  • Romagnani, S. (1995). Biology of Th1 and Th2 cells. Journal of Clinical Immunology, 15, 121–129.

    PubMed  Google Scholar 

  • Rumsey, J. M., & Ernst, M. (in press). Functional neuroimaging of autistic disorders. Invited review. Mental Retardation and Developmental Disabilities Research Reviews.

  • Schandene, L., Vandenbussche, P., Crusiaux, A., Alegre, M. L., Abramowicz, D., DuPont, E., Content, J., & Goldman, M. (1992). Differential effects of pentoxifylline on the production of tumor necrosis factor-alpha (TNF-?) and interleukin-6 (IL-6) by monocytes and T cells. Immunology, 76, 30–34.

    PubMed  Google Scholar 

  • Schwartz, S. A. (1990). Intravenous Immunoglobulin (IVIG) for the therapy of autoimmune disorders. Journal of Clinical Immunology, 10, 81–89.

    PubMed  Google Scholar 

  • Singh, V. K., Warren, R. P., Odell, J. D., Cole, P., & Warren, L. (1993). Antibodies to myelin basic protein in children with autistic behavior. Brain, Behavior and Immnity, 7, 97–103.

    Google Scholar 

  • Singh, V. K., Warren, R. P., Averett, R., & Ghaziuddin M. (1997). Circulating autoantibodies to neuronal and glial filament protein in autism. Pediatric Neurology, 17, 88–90.

    PubMed  Google Scholar 

  • Wakefield, A. J., Murch, S. H., Anthony, A., Linnell, J., Casson, D. M., Malik, M., Berelowitz, M., Dhillon, A. P., Thomson, M. A., Harvey, P., Valentine, A., Davies, S. E., & Walker-Smith, J. A. (1998). Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet, 351, 637–641.

    PubMed  Google Scholar 

  • Warren, R. P, Foster, A., & Margaretten, N. C. (1987). Reduced natural killer cell activity in autism. Journal of the American Academy of Child and Adolescent Psychiatry, 26, 333–335.

    PubMed  Google Scholar 

  • Warren, R. P., Foster, A., Margaretten, N. C., Pace, N. C., & Foster, A. (1986). Immune abnormalities in patients with autism. Journal of Autism and Developmental Disorders, 16, 189–197.

    PubMed  Google Scholar 

  • Warren, R. P., Odell, J. D., Warren, W. L., Burger, R. A., Maciulis, A., Daniles, W. W., & Torres, A. R. (1996). Strong association of the third hypervariable region of HLA-DR??with autism. Journal of Neuroimmunology, 67, 97–102.

    PubMed  Google Scholar 

  • Warren, R. P., Singh, V. K., Cole, P., Odell, J. D., Pingree, C. B., Warren, W. L., & White, E. (1991). Increased frequency of the null allele at the complement C4b locus in autism. Clinical and Experimental Immunology, 83, 438–440.

    PubMed  Google Scholar 

  • Warren, R. P., Singh, V. K., Cole, P., Odell, J. D., Pingree, C. B., Warren, W. L., DeWitt, C. W., & McCullough, M. (1992). Possible association of the extended MHC haplotype B44-SC30-DR4 with autism. Immunogenetics, 36, 203–207.

    PubMed  Google Scholar 

  • Warren, R. P., Yonk, J., Burger, R. W., Odell, D., & Warren, W. L. (1995). DR-positive T cells in autism: Association with decreased plasma levels of the complement C4b protein. Neuropsychobiology, 31, 53–57.

    PubMed  Google Scholar 

  • Yonk, L. J., Warren, R. P., Burger, R. A., Cole, P., Odell, J. D., Warren, W. L., White, E., & Singh, V. K. (1990). CD4??helper T cell depletion in autism. Immunology Letters, 25, 344–346.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Basic and Clinical Immunology, Medical Sciences I, University of California, C-240, Irvine, California, 92697

    Sudhir Gupta

Authors
  1. Sudhir Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gupta, S. Immunological Treatments for Autism. J Autism Dev Disord 30, 475–479 (2000). https://doi.org/10.1023/A:1005568027292

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005568027292

Search

Navigation